Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease

Pasquale Mone; Germano Guerra; Angela Lombardi; Maddalena Illario; Antonella Pansini; Anna Marro; Salvatore Frullone; Alessandro Taurino; Daniela Sorriento; Veronica Verri; Guido Iaccarino; Gaetano Santulli

doi:10.1016/j.phrs.2023.107055

Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease

Pasquale Mone
, Germano Guerra
, Angela Lombardi
, Maddalena Illario
, Antonella Pansini
, Anna Marro
, Salvatore Frullone
, Alessandro Taurino
, Daniela Sorriento
, Veronica Verri
, Guido Iaccarino
, Gaetano Santulli

Medicine

Research output: Contribution to journal › Letter › peer-review

25 Scopus citations

Original language	English (US)
Article number	107055
Journal	Pharmacological Research
Volume	200
DOIs	https://doi.org/10.1016/j.phrs.2023.107055
State	Published - Feb 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Aging
Empagliflozin
Immunology
Lipid pharmacology
SGLT2 inhibitors

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/j.phrs.2023.107055

Cite this

Mone, P., Guerra, G., Lombardi, A., Illario, M., Pansini, A., Marro, A., Frullone, S., Taurino, A., Sorriento, D., Verri, V., Iaccarino, G., & Santulli, G. (2024). Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease. Pharmacological Research, 200, Article 107055. https://doi.org/10.1016/j.phrs.2023.107055

Mone, P, Guerra, G, Lombardi, A, Illario, M, Pansini, A, Marro, A, Frullone, S, Taurino, A, Sorriento, D, Verri, V, Iaccarino, G & Santulli, G 2024, 'Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease', Pharmacological Research, vol. 200, 107055. https://doi.org/10.1016/j.phrs.2023.107055

@article{86a2d3fb13834752970f7b4489796a3e,

title = "Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease",

keywords = "Aging, Empagliflozin, Immunology, Lipid pharmacology, SGLT2 inhibitors",

author = "Pasquale Mone and Germano Guerra and Angela Lombardi and Maddalena Illario and Antonella Pansini and Anna Marro and Salvatore Frullone and Alessandro Taurino and Daniela Sorriento and Veronica Verri and Guido Iaccarino and Gaetano Santulli",

year = "2024",

month = feb,

doi = "10.1016/j.phrs.2023.107055",

language = "English (US)",

volume = "200",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Academic Press",

}

TY - JOUR

T1 - Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease

AU - Mone, Pasquale

AU - Guerra, Germano

AU - Lombardi, Angela

AU - Illario, Maddalena

AU - Pansini, Antonella

AU - Marro, Anna

AU - Frullone, Salvatore

AU - Taurino, Alessandro

AU - Sorriento, Daniela

AU - Verri, Veronica

AU - Iaccarino, Guido

AU - Santulli, Gaetano

PY - 2024/2

Y1 - 2024/2

KW - Aging

KW - Empagliflozin

KW - Immunology

KW - Lipid pharmacology

KW - SGLT2 inhibitors

UR - https://www.scopus.com/pages/publications/85182259889

UR - https://www.scopus.com/pages/publications/85182259889#tab=citedBy

U2 - 10.1016/j.phrs.2023.107055

DO - 10.1016/j.phrs.2023.107055

M3 - Letter

C2 - 38176528

AN - SCOPUS:85182259889

SN - 1043-6618

VL - 200

JO - Pharmacological Research

JF - Pharmacological Research

M1 - 107055

ER -

Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this